Short answer
Rapport Therapeutics, Inc. (RAPP) filed an 8-K current report with the SEC on June 10, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders). Stockholders elected James Healy, Robert Perez, and Raymond Sanchez as Class II directors through the 2029 annual meeting.
Rapport Therapeutics, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.07 · Submission of Matters to a Vote of Security Holders
- Stockholders elected James Healy, Robert Perez, and Raymond Sanchez as Class II directors through the 2029 annual meeting
- Director support varied, with Perez receiving 37,592,089 votes versus 41,762,713 for Healy
- 1,983,035 broker non-votes on each director election, limiting voting participation but not affecting election outcomes
- PwC appointment ratified for fiscal 2026, with 44,255,547 votes for and 57,445 against
- Meeting covered 47,807,623 outstanding shares eligible to vote; no other matters submitted
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Rapport Therapeutics, Inc. 8-K filings
Get the next RAPP 8-K as it lands
Follow RAPP for push alerts, or ask the research agent what this filing means.